首页/数据集/Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine

Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine

NCATS Open Data2022-06-03 更新2026-08-08 收录

疫苗免疫原性

疫苗安全性评估

数据链接：

https://doi.org/10.1101/2022.05.25.22274904 数据链接链接失效反馈

官方服务：

资源简介：

Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine

应用场景：

创建时间：

2022-05-27

疫苗免疫原性

中和抗体动态监测

Female BALB/c mice (4–6 weeks old) were i.p. inoculated with three EV71 FCP-As (V1, V2, and V3) containing 200 U antigen. The sera were isolated and tested at 7, 14, 21, 28, 56 and 84 d post-inoculati

NIAID Data Ecosystem100

Summary of solicited reactogenicity.

疫苗安全性评估

临床监测

Summary of solicited reactogenicity.

Figshare2018-11-02 更新10

Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

疫苗免疫原性

变异株疫苗有效性

Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

NCATS Open Data2022-02-18 更新00

Dataset from Phase IV Open Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-Mumps-Rubella (MMR) Vaccine When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

疫苗免疫原性

疫苗安全性监测

To evaluate the safety and immunogenicity of GSK Biologicals' live attenuated MMR vaccine (Priorix) in a local population in Singapore. The vaccine was administered as a single dose to healthy childre

NIAID Data Ecosystem10

Frequency of neutralization and ADCC antibody responses after the second HIV-MVA and after the second CN54rgp140/GLA-AF immunization.

疫苗免疫原性

抗体反应评价

Frequency of neutralization and ADCC antibody responses after the second HIV-MVA and after the second CN54rgp140/GLA-AF immunization.

NIAID Data Ecosystem10